Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Marel | MAREL | Mar 28, 2024 | 3.20 | +0.63 |
Midkap-index | AMX | Mar 28, 2024 | 930.30 | +0.11 |
Morefield Group | MORE | Mar 28, 2024 | 0.50 | -5.66 |
MotorK Plc | MTRK | Mar 28, 2024 | 4.80 | +1.27 |
Nedap (Nederlandsche Apparatenf) NV | NEDAP | Mar 28, 2024 | 67.60 | -0.59 |
Nederlandse Beleggingsmaatschappij Voor Zeeschepen NV | NBZ | Mar 28, 2024 | 1.10 | 0.00 |
NEPI Rockcastle N.V. | NRP | Mar 28, 2024 | 6.20 | -3.13 |
New Amsterdam Invest N.V. | NAI | Mar 28, 2024 | 9.70 | 0.00 |
Next 150 | N150 | Mar 28, 2024 | 3 394.83 | +0.12 |
NN Group NV | NN | Mar 28, 2024 | 42.82 | +1.09 |
NSI N.V. | NSI | Mar 28, 2024 | 19.00 | 0.00 |
NX Filtration N.V. | NXFIL | Mar 28, 2024 | 4.29 | +28.10 |
OCI N.V. Shs (Netherlands) | OCI | Mar 28, 2024 | 25.39 | -0.82 |
Onward Medical NV | ONWD | Mar 28, 2024 | 4.78 | -0.21 |
Optimix Emerging Markets Fund | OPEMF | Mar 28, 2024 | 58.71 | -0.12 |
Optimix Income Fund | OPTIN | Mar 28, 2024 | 30.84 | +0.19 |
Optimix Mix Fund | OPTMF | Mar 28, 2024 | 37.32 | +0.05 |
PB Holding NV | PBH | Mar 28, 2024 | 2.67 | 0.00 |
Pershing Square Holdings Ltd | PSH | Mar 28, 2024 | 51.60 | +0.98 |
Pharming Group NV | PHARM | Mar 28, 2024 | 1.02 | +0.99 |
Philips KON | PHIA | Mar 28, 2024 | 18.61 | -0.95 |
PostNL NV | PNL | Mar 28, 2024 | 1.26 | +0.88 |
Prosus NV | PRX | Mar 28, 2024 | 29.07 | +1.38 |
Qev N.V. | QEV | Mar 28, 2024 | 7.65 | 0.00 |
Randstad NV | RAND | Mar 28, 2024 | 48.92 | -1.01 |
ReinetInvest | REINA | Mar 28, 2024 | 22.20 | 0.00 |
RELX PLC | REN | Mar 28, 2024 | 40.15 | +0.43 |
Renewi Plc | RWI | Mar 28, 2024 | 6.80 | +1.80 |
Retail Estates | RET | Mar 28, 2024 | 65.00 | -1.07 |
Robeco Afrika Fonds N.V. | RAFRI | Mar 28, 2024 | 83.94 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.